MENU

ELDN Eledon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis... Show more

ELDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ELDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ELDN is expected to report earnings to fall 31.11% to -18 cents per share on November 18

Eledon Pharmaceuticals ELDN Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Missed
by $0.12
Q1'26
Missed
by $0.15
Q4'25
Beat
by $0.10
Q3'25
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of -27 cents, missing the estimate of -15 cents. With 423.19K shares outstanding, the current market capitalization sits at 225.91M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
19800 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
33
Web
https://www.eledon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IDHCX23.630.23
+0.98%
Integrity Dividend Harvest C
WCMNX14.180.13
+0.93%
WCM Small Cap Growth Investor
GGESX27.290.21
+0.78%
Nationwide Schroders Global Eq Instl Svc
FACVX41.750.32
+0.77%
Fidelity Advisor Convertible Secs A
JEMSX53.830.34
+0.64%
JPMorgan Emerging Markets Equity I

ELDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with STRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
N/A
STRO - ELDN
35%
Loosely correlated
-5.44%
RLAY - ELDN
33%
Poorly correlated
-0.11%
NTLA - ELDN
32%
Poorly correlated
-1.59%
DNLI - ELDN
32%
Poorly correlated
-1.45%
ABCL - ELDN
32%
Poorly correlated
+4.11%
More
Eledon Pharmaceuticals (ELDN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com